Mackenzie Financial Corp Biocryst Pharmaceuticals Inc Transaction History

Mackenzie Financial Corp

$65.9 Billion
Q1 2025

A detailed history of Mackenzie Financial Corp transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, Mackenzie Financial Corp holds 116,258 shares of BCRX stock, worth $1.25 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

116,258

Previous 84,662 37.32%

Holding current value

$1.25 Million

Previous $636,000 36.95%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 07, 2025	BUY	$7.06 - $9.39 $223,067 - $296,686	31,596 Added 37.32%	116,258 $871,000
Q4 2024 Feb 14, 2025	BUY	$7.03 - $8.43 $390,411 - $468,160	55,535 Added 190.67%	84,662 $636,000
Q3 2024 Nov 13, 2024	BUY	$6.41 - $8.69 $7,781 - $10,549	1,214 Added 4.35%	29,127 $221,000
Q2 2024 Aug 14, 2024	SELL	$4.13 - $6.79 $17,940 - $29,495	-4,344 Reduced 13.47%	27,913 $172,000
Q1 2024 May 10, 2024	BUY	$4.89 - $7.65 $43,120 - $67,457	8,818 Added 37.62%	32,257 $163,000
Q4 2023 Jan 30, 2024	BUY	$4.98 - $6.77 $49,929 - $67,876	10,026 Added 74.75%	23,439 $140,000
Q3 2023 Oct 25, 2023	SELL	$6.71 - $7.92 $259,468 - $306,258	-38,669 Reduced 74.25%	13,413 $94,000
Q2 2023 Aug 03, 2023	SELL	$6.96 - $8.81 $47,314 - $59,890	-6,798 Reduced 11.55%	52,082 $366,000
Q1 2023 Apr 24, 2023	BUY	$7.94 - $11.84 $297,908 - $444,236	37,520 Added 175.66%	58,880 $491,000
Q4 2022 Feb 14, 2023	SELL	$10.5 - $14.2 $327,883 - $443,423	-31,227 Reduced 59.38%	21,360 $245,000
Q3 2022 Oct 07, 2022	BUY	$10.79 - $14.81 $312,165 - $428,468	28,931 Added 122.3%	52,587 $663,000
Q2 2022 Aug 10, 2022	BUY	$7.89 - $17.88 $46,156 - $104,598	5,850 Added 32.85%	23,656 $250,000
Q1 2022 May 13, 2022	BUY	$11.56 - $19.76 $205,837 - $351,846	17,806 New	17,806 $290,000
Q4 2021 Feb 14, 2022	SELL	$11.18 - $15.46 $116,529 - $161,139	-10,423 Closed	0 $0
Q3 2021 Nov 08, 2021	BUY	$14.21 - $17.65 $148,110 - $183,965	10,423 New	10,423 $150,000

Others Institutions Holding BCRX

# of Institutions

293

Shares Held

177M

Call Options Held

721K

Put Options Held

489K

View Full List

About BIOCRYST PHARMACEUTICALS INC

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $2B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

More about BCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mackenzie Financial Corp with notifications on news.

Account

Mackenzie Financial Corp Biocryst Pharmaceuticals Inc Transaction History